Ashoo Gupta insider trades: 4D Molecular Therapeutics (FDMT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ashoo reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | FDMT | ↓ Sell | 390 | $8.61 | $3K | Direct | Mar 24, 2026 (4d) |
| Dec 20, 2025 | FDMT | ↓ Sell | 389 | $8.68 | $3K | Direct | Dec 23, 2025 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FDMT insiders
Open-market trades in the last 12 months
About Ashoo Gupta's insider trades
Ashoo Gupta is VP, Finance and Controller at 4D Molecular Therapeutics (FDMT). Since Dec 20, 2025, Ashoo has reported no open-market purchases and 2 sales worth $7K on SEC Form 4. In the last 12 months: 2 sales ($7K).
Their filings also include option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FDMT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.